Viewing Study NCT00126061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2025-12-27 @ 5:00 AM
Study NCT ID: NCT00126061
Status: COMPLETED
Last Update Posted: 2015-01-16
First Post: 2005-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects
Sponsor: Solvay Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrial Fibrillation View
None Atrial Flutter View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atrial fibrillation View
None atrial flutter View
None anti-arrhythmic agents View
None conversion to normal sinus rhythm View